Corrigendum to “Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme” [Blood Rev. 2023 Sep:61:101103] (Blood Reviews (2023) 61, (S0268960X23000644), (10.1016/j.blre.2023.101103))

MLA

CDL Rode cel, et al. Corrigendum to “Activation of Pyruvate Kinase as Therapeutic Option for Rare Hemolytic Anemias: Shedding New Light on an Old Enzyme” [Blood Rev. 2023 Sep:61:101103] (Blood Reviews (2023) 61, (S0268960X23000644), (10.1016/j.Blre.2023.101103)). 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1453478901&authtype=sso&custid=ns315887.

APA

CDL Rode cel, Unit Opleiding Aios, Cancer, Haematologie patientenzorg, Poli Van Creveldkliniek Medisch, Child Health, Secretariaat Hematologie, Circulatory Health, CDL Cluster Speciële Diagnostiek, van Dijk, M. J., de Wilde, J. R. A., Bartels, M., Kuo, K. H. M., Glenthøj, A., Rab, M. A. E., van Beers, E. J., & van Wijk, R. (2024). Corrigendum to “Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme” [Blood Rev. 2023 Sep:61:101103] (Blood Reviews (2023) 61, (S0268960X23000644), (10.1016/j.blre.2023.101103)).

Chicago

CDL Rode cel, Unit Opleiding Aios, Cancer, Haematologie patientenzorg, Poli Van Creveldkliniek Medisch, Child Health, Secretariaat Hematologie, et al. 2024. “Corrigendum to ‘Activation of Pyruvate Kinase as Therapeutic Option for Rare Hemolytic Anemias: Shedding New Light on an Old Enzyme’ [Blood Rev. 2023 Sep:61:101103] (Blood Reviews (2023) 61, (S0268960X23000644), (10.1016/j.Blre.2023.101103)).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1453478901&authtype=sso&custid=ns315887.